Purdue Pharma Seeks Vote On New $8B Ch. 11 Plan
By Rick Archer · June 18, 2025, 7:53 PM EDT
Close to a year after the U.S. Supreme Court shot down an earlier version of its Chapter 11 plan, OxyContin maker Purdue Pharma was before a New York bankruptcy judge Wednesday...
To view the full article, register now.